Status:
COMPLETED
PROTECT : Pacing to Protect Heart for Damage From Blocked Heart Vessel and From Re-opening Blocked Vessel(s)
Lead Sponsor:
Guidant Corporation
Conditions:
Acute Myocardial Infarction
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
To determine whether the application of ventricular pacing can protect the human heart from damage resulting from a myocardial infarction
Detailed Description
To determine whether the application of ventricular pacing can protect the human heart from damage resulting from a myocardial infarction
Eligibility Criteria
Inclusion
- Clinical diagnosis of acute myocardial infarction, requiring PCI within 2 to 6 hours following symptoms
- Total occlusion of a coronary artery with reference vessel diameter \>or= 3mm
Exclusion
- Thrombolitics
- Severe bradycardia requiring cardiac pacing
- Previous PCI or CABG
- Recent stroke or CV surgery
- Recent major surgery or trauma
- Clinical and hemodynamic unstability
- Implanted CRM device
- Evidence of previous MI
- Diabetes using rosiglitazone or other fibrates
- Permanent AF
- Mechanical tricuspid valve
- Pregnancy
- Exclusion for MRI
- Incapability of participating in exercise test
Key Trial Info
Start Date :
December 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2009
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT00409604
Start Date
December 1 2006
End Date
August 1 2009
Last Update
August 31 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital of Maastricht (azM)
Maastricht, Netherlands